NAVIGATOR: an Italian regional imaging biobank to promote precision medicine for oncologic patients.

NAVIGATOR is an Italian regional project boosting precision medicine in oncology with the aim of making it more predictive, preventive, and personalised by advancing translational research based on quantitative imaging and integrative omics analyses. The project's goal is to develop an open imaging biobank for the collection and preservation of a large amount of standardised imaging multimodal datasets, including computed tomography, magnetic resonance imaging, and positron emission tomography data, together with the corresponding patient-related and omics-related relevant information extracted from regional healthcare services using an adapted privacy-preserving model. The project is based on an open-source imaging biobank and an open-science oriented virtual research environment (VRE).

West Nile Virus outbreak in Sardinia, Italy, in 2011.

West Nile Virus (WNV) is an enveloped, positive-sense RNA virus belonging to the genus Flavivirus, antigenically related to the Japanese encephalitis complex in the family Flaviviridae. The principal vectors are mosquitoes, in particular Culex spp, and virus amplification seems to occur in susceptible birds that are the principal vertebrate reservoir hosts, whereas humans, horses and other vertebrates are considered incidental or dead-end hosts. The first Italian equine outbreak was reported in late summer of 1998 in Tuscany, in the area surrounding the Fucecchio marshes, where 14 clinical cases of WND in housed equines were recorded.

The impact of the Catholic Jubilee in 2000 on infectious diseases. A case-control study of giardiasis, Rome, Italy 2000-2001.

Mass gatherings are believed to increase the transmission of infectious diseases although surveillance systems have shown a low impact. The Catholic Jubilee was held in Rome, Italy in 2000. We conducted a case-control study to analyse the risk factors of giardiasis among residents.

Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2.

The antibody response following bluetongue (BT) vaccination under both field and experimental conditions, and the duration of colostral antibodies in calves born from vaccinated dams, were evaluated. To this end, 1 005 animals of various breeds and ages were selected at random from 10 herds in the Sardinian province of Oristano. During the first year of the vaccination campaign, the animals selected were vaccinated against BT virus (BTV) serotype 2 between July and August 2002.

Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.

A challenge study was conducted to determine the efficacy of vaccination against bluetongue (BT) virus (BTV) serotype 2 in protecting cattle against infection. A group of 30 cows, vaccinated seven months previously with monovalent BTV-2 modified-live vaccine produced by Onderstepoort Biological Products in South Africa, were challenged subcutaneously with 2x 10(5.8)TCID50/ml of BTV-2 field isolate.